Literature DB >> 2552317

Development of a chromosomal DNA probe for the laboratory diagnosis of aspergillosis.

M A Gabal1.   

Abstract

Chromosomal DNA was extracted from clinical isolates of Aspergillus fumigatus of human and animal origin using the protoplast lysate method. The probe was developed by the nick translation of the chromosomal DNA genome fraction with p32 as the radiolabel. Hybridization of the probe with endonuclease-cleaved DNA of the same species resulted in a pattern of recognition sites specific for the species. The latter was not seen in other species encountered in clinical specimens. Trials were carried out on sputum experimentally inoculated with the fungus where crude DNA was directly extracted, treated with the endonuclease and hybridized with the probe. The efficacy of the probe was as good with the crude as the purified DNA. The specificity of the probe was determined by testing it against single and mixed DNA populations extracted from different species of several fungal and bacterial genera isolated from and/or known to occur in clinical specimens of respiratory infection origin. The sensitivity of the probe was assessed by detecting a DNA concentration in the specimen equivalent to 3 C.F.U.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2552317     DOI: 10.1007/BF00437091

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  12 in total

1.  Increased awareness of aspergillosis in acute leukemia patients.

Authors:  G Höffken; H Rühl; H Seibt; A Meeth; H Lode; H Nekarda; I Wagner; I Horbach; A Rodloff; K Janitschke
Journal:  Haematol Blood Transfus       Date:  1987

2.  Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia.

Authors:  S M Albelda; G H Talbot; S L Gerson; W T Miller; P A Cassileth
Journal:  Am J Med       Date:  1984-06       Impact factor: 4.965

3.  Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use.

Authors:  J Aisner; J Murillo; S C Schimpff; A C Steere
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

4.  Pseudoepidemic of aspergillosis after development of pulmonary infiltrates in a group of bone marrow transplant patients.

Authors:  J J Weems; A Andremont; B J Davis; C H Tancrede; M Guiguet; A A Padhye; F Squinazi; W J Martone
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

Review 5.  Fever and infection in leukemic patients: a study of 494 consecutive patients.

Authors:  G P Bodey; V Rodriguez; H Y Chang
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860

6.  Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia.

Authors:  R S Schwartz; F R Mackintosh; S L Schrier; P L Greenberg
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

7.  Open lung biopsy in patients with acute leukemia.

Authors:  R E McCabe; R G Brooks; J B Mark; J S Remington
Journal:  Am J Med       Date:  1985-04       Impact factor: 4.965

8.  Significance and interpretation of laboratory tests in pulmonary aspergillosis.

Authors:  M P English; A H Henderson
Journal:  J Clin Pathol       Date:  1967-11       Impact factor: 3.411

Review 9.  A guide to the recent literature on aspergillosis as caused by Aspergillus fumigatus, a fungus frequently found in self-heating organic matter.

Authors:  P B Marsh; P D Millner; J M Kla
Journal:  Mycopathologia       Date:  1979-11-30       Impact factor: 2.574

10.  Pulmonary infiltrates in leukemia.

Authors:  M F Tenholder; R G Hooper
Journal:  Chest       Date:  1980-09       Impact factor: 9.410

View more
  1 in total

1.  Comparison of different methods for extraction of DNA of fungal pathogens from cultures and blood.

Authors:  J Löffler; H Hebart; U Schumacher; H Reitze; H Einsele
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.